Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1987 Mar 28;294(6575):801–803. doi: 10.1136/bmj.294.6575.801

Does prophylactic thyroxine treatment after operation for non-toxic goitre influence thyroid size?

L Hegedüs, J M Hansen, D Veiergang, S Karstrup
PMCID: PMC1245863  PMID: 3105748

Abstract

In order to evaluate the influence of thyroxine treatment on thyroid volume after thyroidectomy for non-toxic goitre 110 consecutive patients were randomised to receive thyroxine (150 micrograms daily) or no treatment three months after operation. Thyroid volume determined by ultrasonography did not differ significantly between the two groups one year after operation. Nevertheless, a similar decrease in volume was seen from three to 12 months postoperatively in the thyroxine treated and no treatment groups (median 18 (range 8-70) ml to 16 (range 7-57) ml, and median 20 (range 9-72) ml to 17 (range 8-58) ml, respectively). Three patients (two given thyroxine) had recurrence of goitre within the observation period of one year. In this series thyroid volume decreased during the first postoperative year independently of thyroxine treatment. Hence it seems questionable whether postoperative thyroid function studies can identify patients at risk of recurrence of goitre after operation for non-toxic goitre and whether routine postoperative treatment with thyroxine is justifiable.

Full text

PDF
801

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chiovato L., Hammond L. J., Hanafusa T., Pujol-Borrell R., Doniach D., Bottazzo G. F. Detection of thyroid growth immunoglobulins (TGI) by [3H]-thymidine incorporation in cultured rat thyroid follicles. Clin Endocrinol (Oxf) 1983 Nov;19(5):581–590. doi: 10.1111/j.1365-2265.1983.tb00034.x. [DOI] [PubMed] [Google Scholar]
  2. Clark O. H., Lambert W. R., Cavalieri R. R., Rapoport B., Hammond M. E., Ingbar S. H. Compensatory thyroid hypertrophy after hemithyroidectomy in rats. Endocrinology. 1976 Oct;99(4):988–995. doi: 10.1210/endo-99-4-988. [DOI] [PubMed] [Google Scholar]
  3. Delange F., Hershman J. M., Ermans A. M. Relationship between the serum thyrotropin level, the prevalence of goiter and the pattern of iodine metabolism in Idjwi Island. J Clin Endocrinol Metab. 1971 Aug;33(2):261–268. doi: 10.1210/jcem-33-2-261. [DOI] [PubMed] [Google Scholar]
  4. Dige-Petersen H., Hummer L. Serum thyrotropin concentrations under basal conditions and after stimulation with thyrotropin-releasing hormone in idiopathic non-toxic goiter. J Clin Endocrinol Metab. 1977 Jun;44(6):1115–1120. doi: 10.1210/jcem-44-6-1115. [DOI] [PubMed] [Google Scholar]
  5. Drexhage H. A., Hammond L. J., Bitensky L., Chayen J., Bottazzo G. F., Doniach D. The involvement of the pentose shunt in thyroid metabolism after stimulation with TSH or with immunoglobulins from patients with thyroid disease. 1. The generation of NADPH in relation to stimulation of thyroid growth. Clin Endocrinol (Oxf) 1982 Jan;16(1):49–56. doi: 10.1111/j.1365-2265.1982.tb03146.x. [DOI] [PubMed] [Google Scholar]
  6. Geerdsen J. P., Frølund L. Recurrence of nontoxic goitre with and without postoperative thyroxine medication. Clin Endocrinol (Oxf) 1984 Nov;21(5):529–533. doi: 10.1111/j.1365-2265.1984.tb01391.x. [DOI] [PubMed] [Google Scholar]
  7. Goretzki P., Roeher H. D., Horeyseck G. Prophylaxis of recurrent goiter by high-dose L-thyroxine. World J Surg. 1981 Nov;5(6):855–857. doi: 10.1007/BF01657975. [DOI] [PubMed] [Google Scholar]
  8. Hansen J. M., Kampmann J., Madsen S. N., Skovsted L., Solgaard S., Grytter C., Grontvedt T., Rasmussen S. N. L-thyroxine treatment of diffuse non-toxic goitre evaluated by ultrasonic determination of thyroid volume. Clin Endocrinol (Oxf) 1979 Jan;10(1):1–6. doi: 10.1111/j.1365-2265.1979.tb03027.x. [DOI] [PubMed] [Google Scholar]
  9. Hegedüs L., Perrild H., Poulsen L. R., Andersen J. R., Holm B., Schnohr P., Jensen G., Hansen J. M. The determination of thyroid volume by ultrasound and its relationship to body weight, age, and sex in normal subjects. J Clin Endocrinol Metab. 1983 Feb;56(2):260–263. doi: 10.1210/jcem-56-2-260. [DOI] [PubMed] [Google Scholar]
  10. Husby S., Blichert-Toft M., Bang U., Nielsen B. Investigation of TSH dependency, circulating thyroid autoantibody, and morphological features of recurrent nontoxic goitre. Acta Med Scand. 1985;217(1):61–65. doi: 10.1111/j.0954-6820.1985.tb01635.x. [DOI] [PubMed] [Google Scholar]
  11. LANGE M. J., PIERCY J. E. Recurrent goitre. Lancet. 1957 Jan 26;272(6961):177–181. doi: 10.1016/s0140-6736(57)92486-8. [DOI] [PubMed] [Google Scholar]
  12. LOGOTHETOPOULOS J. H., DONIACH I. Compensatory hypertrophy of the rat thyroid after partial thyroidectomy. Br J Exp Pathol. 1955 Dec;36(6):617–627. [PMC free article] [PubMed] [Google Scholar]
  13. Lewiński A., Bartke A., Smith N. K. Compensatory thyroid hyperplasia in hemithyroidectomized Snell dwarf mice. Endocrinology. 1983 Dec;113(6):2317–2319. doi: 10.1210/endo-113-6-2317. [DOI] [PubMed] [Google Scholar]
  14. Matte R., Ste-Marie L. G., Comtois R., D'Amour P., Lacroix A., Chartrand R., Poisson R., Bastomsky C. H. The pituitary-thyroid axis after hemithyroidectomy in euthyroid man. J Clin Endocrinol Metab. 1981 Aug;53(2):377–380. doi: 10.1210/jcem-53-2-377. [DOI] [PubMed] [Google Scholar]
  15. McMullan N. M., Smyth P. P. In vitro generation of NADPH as an index of thyroid stimulating immunoglobulins (TGI) in goitrous disease. Clin Endocrinol (Oxf) 1984 Mar;20(3):269–280. doi: 10.1111/j.1365-2265.1984.tb00083.x. [DOI] [PubMed] [Google Scholar]
  16. Odell W. D., Wilber J. F., Utiger R. D. Studies of thyrotropin physiology by means of radioimmunoassay. Recent Prog Horm Res. 1967;23:47–85. doi: 10.1016/b978-1-4831-9826-2.50005-2. [DOI] [PubMed] [Google Scholar]
  17. Perrild H., Hansen J. M., Hegedüs L., Rytter L., Holm B., Gundtofte E., Johansen K. Triiodothyronine and thyroxine treatment of diffuse non-toxic goitre evaluated by ultrasonic scanning. Acta Endocrinol (Copenh) 1982 Jul;100(3):382–387. doi: 10.1530/acta.0.1000382. [DOI] [PubMed] [Google Scholar]
  18. Perrild H., Hegedüs L., Arnung K. Sex related goitrogenic effect of lithium carbonate in healthy young subjects. Acta Endocrinol (Copenh) 1984 Jun;106(2):203–208. doi: 10.1530/acta.0.1060203. [DOI] [PubMed] [Google Scholar]
  19. Tannahill A. J., Hooper M. J., England M., Ferriss J. B., Wilson G. M. Measurement of thyroid size by ultrasound, palpation and scintiscan. Clin Endocrinol (Oxf) 1978 Jun;8(6):483–486. doi: 10.1111/j.1365-2265.1978.tb02185.x. [DOI] [PubMed] [Google Scholar]
  20. Toft A. D., Irvine W. J., Hunter W. M. A comparison of plasma TSH levels in patients with diffuse and nodular non-toxic goiter. J Clin Endocrinol Metab. 1976 May;42(5):973–976. doi: 10.1210/jcem-42-5-973. [DOI] [PubMed] [Google Scholar]
  21. Young R. L., Harvey W. C., Mazzaferri E. L., Reynolds J. C., Hamilton C. R. Thyroid-stimulating hormone levels in idiopathic euthyroid goiter. J Clin Endocrinol Metab. 1975 Jul;41(1):21–26. doi: 10.1210/jcem-41-1-21. [DOI] [PubMed] [Google Scholar]
  22. van der Gaag R. D., Drexhage H. A., Wiersinga W. M., Brown R. S., Docter R., Bottazzo G. F., Doniach D. Further studies on thyroid growth-stimulating immunoglobulins in euthyroid nonendemic goiter. J Clin Endocrinol Metab. 1985 May;60(5):972–979. doi: 10.1210/jcem-60-5-972. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES